References
- SullivanRPeppercornJSikoraKDelivering affordable cancer care in high-income countriesLancet Oncol2011121093398021958503
- ChouaidCAtsouKHejblumGVergnenegreAEconomics of treatments for non-small cell lung cancerPharmacoeconomics200927211312519254045
- VergnenègreARayJAChouaidCCross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancerClinicoecon Outcomes Res20124313722347803
- BongersMLCoupéVMJansmaEPSmitEFUyl-de GrootCACost effectiveness of treatment with new agents in advanced non-small- cell lung cancer: a systematic reviewPharmacoeconomics2012301173422201521
- HerbstRSBajorinDFBleibergHClinical cancer advances 2005: major research advances in cancer treatment, prevention, and screening – a report from the American Society of Clinical OncologyJ Clin Oncol200624119020516326753
- SandlerAGrayRPerryMCPaclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerN Engl J Med2006355242542255017167137
- http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfmSilver SpringUS Food and Drug AdministrationBevacizumab [revised May 2012; cited: May 12, 2012]. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125085s0238lbl.pdfAccessed May 27, 2012
- SchragDThe price tag on progress – chemotherapy for colorectal cancerN Engl J Med2004351431731915269308
- ShihYCEltingLSPavluckALStewartAHalpernMTImmunotherapy in the initial treatment of newly diagnosed cancer patients: utilization trend and cost projections for non-Hodgkin’s lymphoma, metastatic breast cancer, and metastatic colorectal cancerCancer Invest2010281465319995227
- Bureau of Labor StatisticsWashingtonUS Bureau of Labor StatisticsConsumer Price Index (All Urban Consumers, item: medical care) [cited May 18, 2012]. Available from: http://data.bls.gov/timeseries/CUUR0000SAMAccessed May 27, 2012
- International Monetary FundWorld Economic Outlook Database [cited May 18, 2012]. Available from: http://www.imf.org/external/pubs/ft/weo/2009/02/weodata/index.aspxAccessed May 27, 2012
- IslaDGonzález-RojasNNievesDBrosaMFinnernHWTreatment patterns, use of resources, and costs of advanced non-small-cell lung cancer patients in Spain: results from a Delphi panelClin Transl Oncol201113746047121775273
- BischoffHGHeigenerDFWalzerSNuijtenMCosts of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and GermanyLung Cancer201069 Suppl 1S18S2320727458
- StanisicSBischoffHGHeigenerDFSocietal cost savings through bevacizumab-based treatment in non-small cell lung cancer (NSCLC)Lung Cancer201069 Suppl 1S24S3020727459
- KleinRMuehlenbeinCLiepaAMBabineauxSWielageRSchwartzbergLCost-effectiveness of pemetrexed plus cisplatin as first-line therapy for advanced nonsquamous non-small cell lung cancerJ Thorac Oncol20094111404141419786904
- GiulianiGGrossiFde MarinisFWalzerSCost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in ItalyLung Cancer201069 Suppl 1S11S1720727457
- GoulartBRamseySA trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancerValue Health201114683684521914503
- AhnMJTsaiCMHsiaTCCost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and TaiwanAsia Pac J Clin Oncol20117 Suppl 2S22S33
- KleinRWielageRMuehlenbeinCCost-effectiveness of pemetrexed as first-line maintenance therapy for advanced nonsquamous non-small cell lung cancerJ Thorac Oncol2010581263127220581708
- ReckMvon PawelJZatloukalPPhase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAilJ Clin Oncol20092781227123419188680
- ReckMvon PawelJZatloukalPOverall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)Ann Oncol20102191804180920150572
- http://www.nccn.org/index.aspFort WashingtonNational Comprehensive Cancer NetworkNCCN clinical practice guidelines in oncologyNon-small cell lung cancer v2.2012 [cited December 17, 2011]. Available from: http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf (free registration required)Accessed December 17, 2011
- WeinsteinMCO’BrienBHornbergerJPrinciples of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices – Modeling StudiesValue Health20036191712535234
- DrummondMFSculpherMJTorranceGWO’BrienBJStoddartGLMethods for the Economic Evaluation of Health Care Programmes3rd edNew YorkOxford University Press2005